New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
09:57 EDTRESI, TMST, SFXE, RCPT, RYAM, NTAP, MBII, EVAR, KONA, IRM, IGXT, ELGX, DVA, CA, VAROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Altisource Residential (RESI) initiated with a Neutral at Citigroup... CA Technologies (CA) initiated with a Buy at Standpoint Research... DaVita (DVA) initiated with a Buy at Jefferies... Endologix (ELGX) initiated with an Outperform at Credit Suisse... IntelGenx (IGXT) initiated with a Buy at H.C. Wainwright... Iron Mountain (IRM) resumed with an Overweight at JPMorgan... Kona Grill (KONA) initiated with a Buy at KeyBanc... Lombard Medical (EVAR) initiated with an Outperform at Credit Suisse... Marrone Bio (MBII) initiated with an Outperform at RW Baird... NetApp (NTAP) initiated with a Buy at Standpoint Research... Rayonier Advanced Materials (RYAM) initiated with a Buy at DA Davidson... Receptos (RCPT) initiated with a Buy at Nomura... SFX Entertainment (SFXE) initiated with an Overweight at Albert Fried... TimkenSteel (TMST) initiated with a Buy at Jefferies... Varian Medical (VAR) initiated with a Neutral at ISI Group... Williams Partners (WPZ) initiated with a Buy at UBS.
News For RESI;CA;DVA;ELGX;IGXT;IRM;KONA;EVAR;MBII;NTAP;RYAM;RCPT;SFXE;TMST;VAR From The Last 14 Days
Check below for free stories on RESI;CA;DVA;ELGX;IGXT;IRM;KONA;EVAR;MBII;NTAP;RYAM;RCPT;SFXE;TMST;VAR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
16:18 EDTCACA Technologies reports Q1 adjusted EPS 65c, consensus 60c
Reports Q1 revenue $1.069B, consensus $1.09B. Q1 cash flow from continuing operations $166M.
July 22, 2014
08:02 EDTVARVarian Medical announces certification of ARIA oncology information system
Subscribe for More Information
07:33 EDTRESIAltisource Residential reports Q2 EPS $1.18, may not compare to consensus 65c
Subscribe for More Information
07:10 EDTMBIIEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration
July 21, 2014
10:02 EDTDVAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:01 EDTCACA Technologies seeks injunction against AppDynamics' use of IP
CA Technologies announced it has filed counterclaims against AppDynamics and its founders, Jyoti Bansal and Bhaskar Sunkara, in a lawsuit pending in the U.S. District Court for the Northern District of California. CA says "It is clear that significant portions of the AppDynamics code was written while its founders were CA employees. CA will take every necessary step to ensure that others do not use its code or infringe its patents. CA is seeking a court declaration that it owns the code written prior to Bansal's and Sunkara's departure from CA as well as any derivative works. CA is also seeking an injunction against AppDynamics prohibiting the misuse of CA's intellectual property and financial damages. The claims filed today allege that Bansal and Sunkara secretly began to develop an Application Performance Monitoring product and business to compete directly with CA while they were still CA employees. CA maintains that these actions occurred after CA acquired Wily Technologies, its APM product and its key software engineers in 2006. CA alleges these actions violated obligations Bansal and Sunkara had under agreements with CA, breached duties they owed under law and infringed CA's intellectual property rights."
08:43 EDTRYAMRayonier declares special cash dividend of 50c per share
Rayonier's (RYN) board of directors has declared a third quarter cash dividend of 30c per common share. The dividend is payable on September 30 to shareholders of record on September 16. In addition to the regular third quarter cash dividend, the company’s board has declared a special cash dividend of 50c per common share payable on August 15 to shareholders of record on July 31. The special dividend will be paid from proceeds received from Rayonier Advanced Materials (RYAM) in connection with its spin-off from Rayonier on June 27.
08:01 EDTVARVarian Medical receives FDA clearance for Calypso Beacon transponder
Subscribe for More Information
07:14 EDTVARAmerican Association of Physicists in Medicine to hold annual meeting
56th Annual Meeting of AAPM to be held in Austin, Texas on July 20-25.
05:43 EDTDVADaVita downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
July 18, 2014
16:05 EDTDVADaVita says CEO of HealthCare Partners subsidiary to step down
DaVita HealthCare Partners announced that HealthCare Partners, or HCP, president and CEO Dr. Craig Samitt is stepping down from HCP effective August 1. Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners, will take over the role of CEO of HCP, working in tandem with the office of Chief Medical Officer.
10:03 EDTKONA, RYAMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:03 EDTIRMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:42 EDTIRMIron Mountain downgraded at RW Baird
As previously reported, Baird downgraded Iron Mountain to Neutral from Outperform. The firm expects the REIT conversion will require significant capital commitments due to the high dividend, which will leave little capital for larger growth investments. Additionally, the analyst believe equity dilution risk is not fully appreciated. Price target lowered to $39 from $40.
06:56 EDTRYAMRayonier Advanced Materials initiated with an Underperform at BofA/Merrill
Subscribe for More Information
06:11 EDTIRMIron Mountain downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
July 17, 2014
19:23 EDTKONAKona Grill initiated with an Outperform at Wedbush
Subscribe for More Information
12:15 EDTNTAPSanDisk plummets after Q3 revenue outlook disappoints
Subscribe for More Information
09:29 EDTTMSTTimkenSteel to invest $40M in additional continous heat-treat facility
Subscribe for More Information
07:00 EDTDVAFresenius Medical shares should be bought, says Bernstein
Bernstein notes that Fresenius' (FMS) stock has sharply underperformed versus its competitor, DaVita (DVA), since May 2012. But the firm predicts that Fresenius' core U.S. business should outperform that of DaVita going forward. Bernstein adds that it finds Fresenius' business units aside from its U.S. dialysis clinics more attractive than DaVita's businesses other than its U.S. dialysis clinics.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use